Graphene Oxide Coatings as Tools to Prevent Microbial Biofilm Formation on Medical Device.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
pubmed: 31 8 2019
medline: 17 12 2020
entrez: 31 8 2019
Statut: ppublish

Résumé

The clinical challenge on surface engineering of medical devices to prevent microorganisms adhesion and biofilm formation, has become an essential aspect for medical implants. Antibacterial properties of Graphene Oxide (GO) have been demonstrated across a broad spectrum of bacteria, and the different mechanisms of action with which this nanomaterial interacts with the microbial surface have been elucidated in detail. Innovative protective coatings based on graphene film and hydrogel could represent an innovative solution for the prevention of nosocomial pathogens colonization on implantable device. This brief review mainly focuses on the applications of graphene in nanomedicine with a particular deepening on the antibacterial properties of GO and GO-based nanomaterials. In order to evaluate the possible future applications of GO as an anti-biofilm coating material for medical devices, studies on the ability of graphene coated surface to prevent microbial adhesion are also discussed. A concise review on in vitro toxicity and in vivo safety is also presented.

Identifiants

pubmed: 31468360
doi: 10.1007/5584_2019_434
doi:

Substances chimiques

Anti-Bacterial Agents 0
Coated Materials, Biocompatible 0
graphene oxide 0
Graphite 7782-42-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-35

Auteurs

Margherita Cacaci (M)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy.

Cecilia Martini (C)

Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy.

Cinzia Guarino (C)

Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy.

Riccardo Torelli (R)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Francesca Bugli (F)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Francesca.bugli@unicatt.it.
Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy. Francesca.bugli@unicatt.it.

Maurizio Sanguinetti (M)

Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH